Translocation domain of botulinum neurotoxin A subtype 2 potently induces entry into neuronal cells
- 17 April 2020
- journal article
- research article
- Published by Wiley in Microbiology and Immunology
- Vol. 64 (7), 502-511
- https://doi.org/10.1111/1348-0421.12796
Abstract
Botulinum neurotoxin (BoNT) is the causative agent of botulism in humans and animals. Only BoNT serotype A subtype 1 (BoNT/A1) is clinically used because of its high potency and long duration of action. BoNT/A1 and BoNT/A subtype 2 (BoNT/A2) have high degree of amino acid sequence similarity in light chain (LC) (96%), whereas their N‐and C‐terminal heavy chain (HN and HC) differ by 13%. LC acts as a zinc‐dependent endopeptidase, HN as the translocation domain, and HC as the receptor‐binding domain. BoNT/A2 and BoNT/A1 had similar potency in mouse bioassay, but BoNT/A2 entered faster and more efficiently into neuronal cells. To identify domains responsible for these characteristics, HN of BoNT/A1 and BoNT/A2 was exchanged to construct chimeric BoNT/A121 and BoNT/A212. After expression in E. coli, chimeric and wild‐type BoNT/As were purified as single‐chain proteins and activated by conversion to disulfide‐linked dichains. Toxicities of recombinant wild‐type and chimeric BoNT/As were similar, but it dropped to 60% compared with the values of native BoNT/As. The relative orders of SNAP‐25 cleavage activity in neuronal cells and toxicity differed. BoNT/A121 and recombinant BoNT/A2 have similar SNAP‐25 cleavage activity. BoNT/A2 HN is possibly responsible for the higher potency of BoNT/A2 than BoNT/A1.Keywords
This publication has 31 references indexed in Scilit:
- Botulinum Neurotoxin Serotype a Specific Cell-Based Potency Assay to Replace the Mouse BioassayPLOS ONE, 2012
- P19 embryonal carcinoma cells exhibit high sensitivity to botulinum type C and D/C mosaic neurotoxinsMicrobiology and Immunology, 2012
- Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1FEBS Letters, 2010
- Characterization of the D/C mosaic neurotoxin produced by Clostridium botulinum associated with bovine botulism in JapanVeterinary Microbiology, 2010
- Catalytic Properties of Botulinum Neurotoxin Subtypes A3 and A4Biochemistry, 2009
- Botulinum Neurotoxin Devoid of Receptor Binding Domain Translocates Active ProteasePLoS Pathogens, 2008
- Identification of the receptor-binding sites in the carboxyl-terminal half of the heavy chain of botulinum neurotoxin types C and DMicrobial Pathogenesis, 2008
- Long-Distance Retrograde Effects of Botulinum Neurotoxin AJournal of Neuroscience, 2008
- Binding of Clostridium botulinum Type C and D Neurotoxins to Ganglioside and PhospholipidOnline Journal of Public Health Informatics, 2005
- Covalent structure of botulinum neurotoxin type A: Location of sulfhydryl groups, and disulfide bridges and identification of C-termini of light and heavy chainsJournal of Protein Chemistry, 1994